- Report
- June 2025
- 50 Pages
Global
From €2382EUR$2,650USD£2,020GBP
Pantoprazole is a proton pump inhibitor (PPI) used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. It is also used to reduce the risk of stomach ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Pantoprazole works by decreasing the amount of acid produced in the stomach.
Pantoprazole is available in both prescription and over-the-counter forms. It is available as a tablet, capsule, and powder for suspension. It is also available in combination with other medications, such as amoxicillin and clarithromycin, for the treatment of Helicobacter pylori infection.
The Pantoprazole market is a part of the larger Gastrointestinal Drugs market. This market includes a variety of drugs used to treat gastrointestinal disorders, such as antacids, proton pump inhibitors, H2 receptor antagonists, and prokinetics. These drugs are used to treat a wide range of gastrointestinal disorders, including GERD, peptic ulcer disease, irritable bowel syndrome, and inflammatory bowel disease.
Some companies in the Pantoprazole market include AstraZeneca, Pfizer, Takeda Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more